Slumping Instrument Sales Drag Thermo Fisher Revenues Down 8 Percent in Q2 | GenomeWeb

Thermo Fisher Scientific said today that revenues for its Analytical Technologies segment, which houses its mass spectrometers, dipped 14 percent for the second quarter, year over year.

For the three months ended June 27, Analytical Technologies receipts totaled $1 billion, down from $1.16 billion in the year-ago period.

The company's total receipts declined 8 percent to $2.48 billion for the quarter from $2.71 billion in the second quarter of 2008. The effects of foreign currency drove down revenues 4 percent, the company said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.